Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Pan S.-L.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 28 到 46 筆資料,總共 46 筆
< 上一頁
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2014
Moniliformediquinone induces in vitro and in vivo antitumor activity through glutathione involved DNA damage response and mitochondrial stress in human hormone refractory prostate cancer
Hsu J.-L.; Lee Y.-J.; Leu W.-J.; Dong Y.-S.; Pan S.-L.; Uang B.-J.; JIH-HWA GUH
Journal of Urology
12
11
2008
Moscatilin induces apoptosis in human colorectal cancer cells: A crucial role of c-Jun NH2-terminal protein kinase activation caused by tubulin depolymerization and DNA damage
Chen T.-H.; Pan S.-L.; JIH-HWA GUH
; Liao C.-H.; Huang D.-Y.; Chen C.-C.; Teng C.-M.
Clinical Cancer Research
51
41
2010
Moscatilin repressed lipopolysaccharide-induced hif-1α accumulation and NF-κB activation in murine raw264.7 cells
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH
; Chen C.-C.; Shen C.-C.; Teng C.-M.
Shock
28
26
2010
Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo
Tsai A.-C.; Pan S.-L.; Liao C.-H.; JIH-HWA GUH
; Wang S.-W.; Sun H.-L.; Liu Y.-N.; Chen C.-C.; Shen C.-C.; Chang Y.-L.; Teng C.-M.
Cancer Letters
59
48
2019
MPT0G413, A novel HDAC6-selective inhibitor, and bortezomib synergistically exert anti-tumor activity in multiple myeloma cells
Huang F.-I.; Wu Y.-W.; Sung T.-Y.; Liou J.-P.; Lin M.-H.; Pan S.-L.; CHIA-RON YANG
Frontiers in Oncology
19
18
2021
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo
Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG
; Yen S.-C.; HuangFu W.-C.; Pan S.-L.
Oncogenesis
15
16
2014
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i
Yu C.-C.; Pan S.-L.; Chao S.-W.; SHIH-PING LIU
; Hsu J.-L.; Yang Y.-C.; TSAI-KUN LI
; Huang W.-J.; JIH-HWA GUH
Biochemical Pharmacology
29
28
2022
O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia
Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG
; HuangFu W.-C.; Pan S.-L.; Hsu K.-C.
Phytomedicine
5
5
2005
A potential role of YC-I on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models
Pan S.-L.; JIH-HWA GUH
; Peng C.-Y.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-H.
Thrombosis and Haemostasis
32
31
2012
Protopine, a novel microtubule-stabilizing agent, causes mitotic arrest and apoptotic cell death in human hormone-refractory prostate cancer cell lines
Chen C.-H.; Liao C.-H.; Chang Y.-L.; JIH-HWA GUH
; Pan S.-L.; Teng C.-M.
Cancer Letters
55
49
2012
QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells
Chen M.-C.; Pan S.-L.; Shi Q.; Xiao Z.; Lee K.-H.; TSAI-KUN LI
; Teng C.-M.
Cancer Science
15
13
2007
Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways
Chen Y.-C.; Lu P.-H.; Pan S.-L.; Teng C.-M.; Kuo S.-C.; Lin T.-P.; Ho Y.-F.; Huang Y.-C.; JIH-HWA GUH
Biochemical Pharmacology
58
59
2014
Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer [Strahleninduzierte VEGF-C-Expression und endotheliale Zellteilung bei Lungenkrebs]
YU-HSUAN CHEN
; Pan S.-L.; Wang J.-C.; SUNG-HSIN KUO
; CHIA-HSIEN CHENG
; Teng C.-M.
Strahlentherapie und Onkologie
30
31
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G 0-G1 in human hepatocellular carcinoma cells
Wang S.-W.; Pan S.-L.; JIH-HWA GUH
; Chen H.-L.; Huang D.-M.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
47
47
2005
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models
Pan S.-L.; JIH-HWA GUH
; Peng C.-Y.; Wang S.-W.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
55
53
2006
YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH
; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Journal of Pharmacology and Experimental Therapeutics
39
33
2008
YC-1 induces heat shock protein 70 expression and prevents oxidized LDL-mediated apoptosis in vascular smooth muscle cells
Liu Y.-N.; Pan S.-L.; Peng C.-Y.; Huang D.-Y.; JIH-HWA GUH
; Kuo S.-C.; Lee F.-Y.; Teng C.-M.
Shock
12
10
2007
YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia
Sun H.-L.; Liu Y.-N.; Huang Y.-T.; Pan S.-L.; Huang D.-Y.; JIH-HWA GUH
; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
Oncogene
163
158
2005
YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells
Huang Y.-T.; Pan S.-L.; JIH-HWA GUH
; Chang Y.-L.; Lee F.-Y.; Kuo S.-C.; Teng C.-M.
Molecular Cancer Therapeutics
45
43